NP Life Sciences Health Industry Group Inc. (ACAT) stock: key figures, P/E, revenue and dividend

Consumer Discretionary · United States

Price
10.00 USD
Market cap
42.96 m USD
P/E (2024)
–
P/S (2024)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

NP Life Sciences Health Industry Group Inc. financials

Fiscal year2023
Revenue164,621.00 USD
Operating income-690.00 USD
EBIT-690.00 USD
Net income-2,935.00 USD
Diluted EPS – continuing operations0.00 USD

Full history since 2018, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About NP Life Sciences Health Industry Group Inc.

Acasia Technology, Inc., technology development company, develops various entertainment experiences. It provides players and creators with the tools to design, explore, and share interactive worlds. The company's platform integrates AI-powered content generation, dynamic gameplay systems, and robust social connectivity features to a digital ecosystem. Acasia Technology, Inc. was formerly known as NP Life Sciences Health Industry Group Inc. and changed its name to Acasia Technology, Inc. in May 2025. The company was incorporated in 2018 and is based in Minneapolis, Minnesota.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.